The ROE as of September 2024 (TTM) for Surgalign Holdings, Inc. (SRGA) is 416.30%

According to Surgalign Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is 416.30%. This represents a change of 7.02% compared to the average of 5.85% of the last 4 quarters.

Surgalign Holdings, Inc. (SRGA) Historical ROE (quarterly & annually)

How has SRGA ROE performed in the past?

The mean historical ROE of Surgalign Holdings, Inc. over the last ten years is -280.98%. The current 416.30% ROE has changed -248.16% with respect to the historical average. Over the past ten years (40 quarters), SRGA's ROE was at its highest in in the June 2020 quarter at 193.94%. The ROE was at its lowest in in the December 2021 quarter at -1078.32%.

Surgalign Holdings, Inc. (SRGA) ROE by Quarter and Year

Discovering the peaks and valleys of Surgalign Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Surgalign Holdings, Inc. (SRGA) Average ROE

How has SRGA ROE performed in the past?

The current ROE of Surgalign Holdings, Inc. (SRGA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Surgalign Holdings, Inc. (SRGA) ROE vs. Peers

How is SRGA’s ROE compared to its peers?

Surgalign Holdings, Inc.’s ROE is greater than NuVasive, Inc. (3.46%), greater than Paragon 28, Inc. (-33.34%), greater than Orthofix Medical Inc. (-20.68%), greater than SI-BONE, Inc. (-24.27%), greater than Avanos Medical, Inc. (0.63%), less than Aziyo Biologics, Inc. (196.38%), greater than Establishment Labs Holdings Inc. (-220.67%), greater than CVRx, Inc. (-77.62%), greater than AxoGen, Inc. (-17.30%), greater than Talis Biomedical Corporation (-79.73%), greater than Heart Test Laboratories, Inc. (-191.71%), greater than Tivic Health Systems, Inc. (-172.08%), greater than Bone Biologics Corporation (-154.16%), greater than Bioventus Inc. (-24.93%), greater than Surmodics, Inc. (-1.16%), greater than Biomerica, Inc. (-69.21%), greater than Movano Inc. (-452.96%), greater than Ainos, Inc. (-64.53%), greater than INVO Bioscience, Inc. (-1073.76%), greater than Hyperfine, Inc. (-51.71%), greater than Inogen, Inc. (-45.37%), less than Accelerate Diagnostics, Inc. (131.18%), greater than Apyx Medical Corporation (-119.38%),

Build a custom stock screener for Surgalign Holdings, Inc. (SRGA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surgalign Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Surgalign Holdings, Inc. (SRGA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Surgalign Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.